Scheme 1. A Strategy for the Synthesis of H-Phosphinates Based
on the Hydroxymethyl Protecting Groupa
Scheme 2. Activation/Nucleophilic Displacement of (Hydroxy-
methyl)phosphinate 1aa
a See Supporting Information for detailed experimental procedures.
DPM = diphenylmethyl, Ph2CH. (a) (i) N-Chlorosuccinimide (1.5 equiv),
Me2S (1.5 equiv), CH2Cl2, À78 °C, 10 min; (ii) R1P(O)(OR2)CH2OH
(1 equiv), À78 °C, 1 h; (iii) Et3N (5 equiv), À78 °C to rt, 1 h. (b) (i)
H2NNH2 (3 equiv), THF, rt, 16 h; (ii) Boc2O (5 equiv), i-Pr2NEt (5 equiv),
THF, rt, 4 h. (c) (i) H2NNH2 (4 equiv), THF, rt, 16 h; (ii) Me2NCH2COOH
(5 equiv), HOBt (5 equiv), EDC (5 equiv), CH2Cl2, rt, 2h. (d) TsCl(2equiv),
a (a) TsCl (2 equiv), i-Pr2NEt (2.5 equiv), CH2Cl2, rt, 24 h. (b) Bn2NH
(1.5 equiv), K2CO3 (3 equiv), CH3CN, reflux, 48 h. (c) Piperidine
(1.5 equiv), K2CO3 (2 equiv), CH3CN, reflux, 16 h. (d) (i-PrO)2P(O)H
(1.5 equiv), NaH (2 equiv), CH2Cl2, rt, 20 h. (e) NaI (4 equiv), acetone,
reflux, 24 h. (f) ClP(O)(OPh)2 (1.5 equiv), TiCl4 (2 mol %), Et3N
(1.5 equiv), CH2Cl2, rt, 6 h. (g) (i) SOCl2 (1.5 equiv), pyridine
(1.2 equiv), 50 °C, 20 h; (ii) BuOH. (h) Phthalimide (1.3 equiv), PyPPh2
(1.3 equiv), DIAD (1.3 equiv), CH2Cl2, rt, 24 h.
˚
i-Pr2NEt (2.5 equiv), CH2Cl2,rt,24h.(e) i-PrOH (solvent), 4 A MS, reflux, 3 h.
aminomethyl-H-phosphinates 6a and 6b and 8 were cho-
sen because compounds of this type are very useful inter-
mediates, often prepared through cumbersome sequences
on limited scales.11 Interestingly, compound 5a is isolated
as a solid, thus avoiding the need for chromatography.
Direct oxidation of 5a gave 6a, but unfortunately pure 6a
could not be obtained because it is not very stable (purity
∼85%). Therefore crude 6a was treated with i-PrOH and
transesterification to isopropyl ester 8 proceeded in good
yield and purity (68% from 5a). Intermediate 5a was also
converted into the Boc-protected 5b which could then be
oxidatively deprotected into 6b. Conversion of 5a into the
N,N-dimethylglycine amide 5c was uneventful. Depro-
tected 5c is a known bacterial urease inhibitor.2a Finally
tosylation of 5a gave compound 7.
we next turned our attention to reactions in which the
methylene carbon is preserved. As mentioned earlier, this
type ofreactionalthough not unprecedentedissurprisingly
rare.1p,q Butyl (hydroxymethyl)phenyl phosphinate 1a
was chosen as a representative model compound.12 The
first type of reaction investigated was the activationÀ
nucleophilic substitution sequence, which has been useful
in the chemistry of phosphonates.1n,o Results are shown in
Scheme 2. Tosylation to 9 was achieved in excellent yield
under standard conditions. Displacement with a variety of
nucleophiles proceeded in good to excellent yields. For
example, the formation of 10aÀb with secondary amines
takes place uneventfully.
Interestingly, reacting 9 with diisopropylphosphite
under MichaelisÀBecker conditions smoothly delivered
(phosphinylmethyl)phosphonate 11.13 This type of com-
pound is of interest for the preparation of biologically
active pyrophosphate analogs. The (phosphinylmethyl)-
phosphate motif is an emerging but underutilized mimic
for pyrophosphate and phosphoryl transfer.14 Pre-
cursor 12a was easily synthesized from alcohol 1a.15
Having established the oxidative cleavage of (hydroxy-
methyl)phosphinates 1 as a viable synthetic methodology,
(11) For example, see: (a) Yamagishi, T.; Mori, J.-i.; Haruki, T.;
Yokomatsu, T. Tetrahedron: Asymmetry 2011, 22, 1358. (b) Yamagishi,
T.; Ichikawa, H.; Haruki, T.; Yokomatsu, T. Org. Lett. 2008, 10, 4347.
(c) Li, S.; Whitehead, J. K.; Hammer, R. P. J. Org. Chem. 2007, 72, 3116.
(d) Yamagishi, T.; Haruki, T.; Yokomatsu, T. Tetrahedron 2006, 62,
9210. (e) Zhukov, Y. N.; Vavilova, N. A.; Osipova, T. I.; Khurs, E. N.;
Dzhavakhiya, V. G.; Khomutov, R. M. Mendeleev Commun. 2004, 93.
(f) Cristau, H.-J.; Coulombeau., A.; Genevois-Borella, A.; Sanchez, F.;
Pirat, J.-L. J. Organomet. Chem. 2002, 643À644, 381. (g) Buchardt, J.;
Ferreras, M.; Krog-Jensen, C.; Delaisse, J.-M.; Foged, N. T.; Meldal,
M. Chem.;Eur. J. 1999, 5, 2877. (h) Dorff, P. H.; Chiu, G.; Goldstein,
S. W.; Morgan, B. P. Tetrahedron Lett. 1998, 39, 3375. (i) Verbruggen,
C.; De Craecker, S.; Rajan, P.; Jiao, X.-Y.; Borloo, M.; Smith, K.;
Fairlamb, A. H.; Haemers, A. Bioorg. Med. Chem. Lett. 1996, 6, 253.
(j) Grobelny, D. Synth. Commun. 1989, 19, 1177. (k) Dingwall, J. G.;
Ehrenfreund, J.; Hall, R. G. Tetrahedron 1989, 45, 3787. (l) Natchev,
I. A. Liebigs Ann. Chem 1988, 861. (m) Baylis, E. K.; Campbell, C. D.;
Dingwall, J. G. J. Chem. Soc., Perkin Trans. 1 1984, 2845.
(12) PhP(O)(OBu)CH2OH 1a was prepared in one pot and 83% yield
from commercially available phenyl-H-phosphinic acid through
DeanÀStark esterification (n-BuOH, 5 equiv, toluene, 24 h) followed
by reaction with paraformaldehyde (1 equiv, reflux, 24 h). See Support-
ing Information.
(13) For a related reaction, see: Hall, R. G.; Kane, P. D.; Bittiger, H.;
Froestl, W. J. Labelled Compd. Radiopharm. 1995, 36, 129.
(14) (a) Guranowski, A.; Starzynska, E.; Pietrowska-Borek, M.;
Rejman, D.; Blackburn, G. M. FEBS J. 2009, 276, 1546. (b) Nguyen,
L. M.; Niesor, E.; Bentzen, C. L. J. Med. Chem. 1987, 30, 1426.
3406
Org. Lett., Vol. 14, No. 13, 2012